Literature DB >> 4500985

Cataract after busulphan treatment.

M P Ravindranathan, V J Paul, E T Kuriakose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4500985      PMCID： PMC1789202          DOI： 10.1136/bmj.1.5794.218

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Ocular involvement in leukemia and allied disorders.

Authors:  R A ALLEN; B R STRAATSMA
Journal:  Arch Ophthalmol       Date:  1961-10

2.  The lens epithelium in the pathogenesis of cataract; the XIII Edward Jackson Memorial lecture.

Authors:  L VON SALLMANN
Journal:  Am J Ophthalmol       Date:  1957-08       Impact factor: 5.258

3.  Myleran in chronic myeloid leukaemia; results of treatment.

Authors:  D A GALTON
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

4.  Lens changes in chronic granulocytic leukemia. Possible relationship to chemotherapy.

Authors:  S M Podos; G P Canellos
Journal:  Am J Ophthalmol       Date:  1969-09       Impact factor: 5.258
  4 in total
  5 in total

1.  Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse.

Authors:  John A Turton; William R Sones; Charles M Andrews; Andrew M Pilling; Thomas C Williams; Gemma Molyneux; Sian Rizzo; Edward C Gordon-Smith; Frances M Gibson
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

2.  Ocular complications in a young pediatric population following bone marrow transplantation.

Authors:  Mary Ellen Hoehn; Julie Calderwood; Edwin Gannon; Brittany Cook; Richard Rochester; Christine Hartford; Brandon Triplett; Anusha Sunkara; Guolian Kang; R Christopher Walton
Journal:  J AAPOS       Date:  2018-01-05       Impact factor: 1.220

3.  Histopathology and ultrastructure of busulfan-induced cataract.

Authors:  N A Hamming; D J Apple; M F Goldberg
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-08-30

Review 4.  The role of busulfan in bone marrow transplantation.

Authors:  M Hassan
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

5.  Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.

Authors:  P S Ganly; C Arthur; J M Goldman; W E Schulenburg
Journal:  Postgrad Med J       Date:  1988-05       Impact factor: 2.401
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.